Exploration of Pyrido[3,4-<i>d</i>]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2
Upregulated CXCR2 signalling is found in numerous inflammatory, autoimmune and neurodegenerative diseases, as well as in cancer. Consequently, CXCR2 antagonism is a promising therapeutic strategy for treatment of these disorders. We previously identified, via scaffold hopping, a pyrido[3,4-<i>...
Main Authors: | Max Van Hoof, Sandra Claes, Katrijn Boon, Tom Van Loy, Dominique Schols, Wim Dehaen, Steven De Jonghe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/5/2099 |
Similar Items
-
Synthetic Pathways to Pyrido[3,4-<i>c</i>]pyridazines and Their Polycyclic Derivatives
by: Temitayo Omowumi Alegbejo Price, et al.
Published: (2022-10-01) -
Studies of Interaction Mechanism between Pyrido [3,4-<i>d</i>] Pyrimidine Inhibitors and Mps1
by: Cheng Xing, et al.
Published: (2021-08-01) -
Synthesis and Anti-HIV Activity of a Novel Series of Isoquinoline-Based CXCR4 Antagonists
by: Mastaneh Safarnejad Shad, et al.
Published: (2021-10-01) -
Design, Synthesis and Bioactivity Evaluation of 4,6-Disubstituted Pyrido[3,2-<i>d</i>]pyrimidine Derivatives as Mnk and HDAC Inhibitors
by: Kun Xing, et al.
Published: (2020-09-01) -
Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications
by: Guillem Jubete, et al.
Published: (2019-11-01)